Action PTPI PETROS PHARMACEUTICALS, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués Petros Pharmaceuticals, Inc.

Actions

PTPI

US71678J2096

Marché Fermé - Nasdaq
Autres places de cotation
 22:30:00 05/07/2024 		Varia. 5j. Varia. 1 janv.
0,415 USD -2,15 % Graphique intraday de Petros Pharmaceuticals, Inc. -9,29 % -70,57 %
29/05 Petros Pharmaceuticals termine avec succes une etude formative des facteurs humains integree a l'IA demontrant une interaction positive avec l'application Web concue pour le passage a STENDRA(R) (avanafil) en vente libre CI
15/05 Petros Pharmaceuticals, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024 CI

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Petros Pharmaceuticals Successfully Completes AI-Integrated Formative Human Factors Study Demonstrating Positive Interaction with Web App Designed for STENDRA OTC Switch
AQ
Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros Pharmaceuticals
AQ
Petros Pharmaceuticals announces online distribution for lead ED product with Lemonaid Health
AQ
Petros Pharmaceuticals Expands Online Distribution for Prescription STENDRA through New Agreement with Lemonaid Health
AQ
BestGrowthStocks.Com Issues Comprehensive Analysis of Petros Pharmaceuticals Inc
AQ
Thinking about buying stock in Helius Medical Technologies, Peraso, GDS Holdings, Everbridge, or Petros Pharmaceuticals?
PR
Petros Pharmaceuticals Announces Two Upcoming FDA Meetings to Review Progress and Path Forward for STENDRA Rx-to-OTC Switch
AQ
Petros Pharmaceuticals Demonstrates Positive Results Following Successful Completion of Initial Cohort of Phase 2 Equivalent Self-Selection Study for STENDRA Rx-to-OTC Switch
AQ
Petros Pharmaceuticals Successfully Completes Important Study in Effort to Make STENDRA the First Erectile Dysfunction Medication to Achieve OTC Status
AQ
Petros Pharmaceuticals Partners with Blockbuster Cholesterol Drug(1) Crestor's OTC Switch Technology Provider
AQ
Petros Pharmaceuticals Petros Pharmaceuticals Developing Artificial Intelligence Technology for Phase 2 Equivalent Study for STENDRA
AQ
Petros Pharmaceuticals to Present at the LD Micro Main Event XVI
AQ
Petros Pharmaceuticals : Modification to Rights of Security Holders - Form 8-K
PU
Petros Pharmaceuticals Provides Letter to Shareholders
AQ
CapitalGainsReport: Men's Wellness Watchlist (MGRX, OTRK, HIMS, PTPI)
AQ
Men's Wellness Stocks Watchlist (MGRX, OTRK, HIMS, PTPI)
AQ
CapitalGainsReport: Unlocking Opportunities in Men's Health Stocks (MGRX, HIMS, TDOC, PTPI)
AQ
PETROS PHARMACEUTICALS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
PETROS PHARMACEUTICALS, INC. : Material Modification to Rights of Security Holders, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
PETROS PHARMACEUTICALS, INC. : Results of Operations and Financial Condition (form 8-K)
AQ
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action PTPI
  4. Actualités Petros Pharmaceuticals, Inc.
  5. Communiqués